{"id":"NCT00833703","sponsor":"Sanofi","briefTitle":"Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation","officialTitle":"Long Term Safety Study in Patients Included in the CLARINET Study With Cyanotic Congenital Heart Disease Palliated With a Systemic-to-pulmonary Artery Shunt and for Whom the Shunt is Still in Place at One Year of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-01","primaryCompletion":"2010-07","completion":"2010-07","firstPosted":"2009-02-02","resultsPosted":"2011-08-16","lastUpdate":"2011-08-22"},"enrollment":49,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Heart Defects, Congenital"],"interventions":[{"type":"DRUG","name":"Clopidogrel","otherNames":["SR25990","Plavix"]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Clopidogrel 0.2 mg/kg/day","type":"EXPERIMENTAL"}],"summary":"This study is the extension of the CLARINET study \\[NCT00396877 -EFC5314\\] in neonates or infants with cyanotic congenital heart disease palliated with a systemic-to-pulmonary artery shunt.\n\nThe primary objective was to assess the safety up to 18 months of age of the extended use of Clopidogrel 0.2 mg/kg/day in patients for whom the shunt was still in place at one year of age.\n\nThe secondary objective was to assess the efficacy on the occurrence of shunt thrombosis requiring intervention or any death.","primaryOutcome":{"measure":"Number of Participants With Bleeding Events","timeFrame":"Up to a maximum of 6 months","effectByArm":[{"arm":"Placebo","deltaMin":0,"sd":null},{"arm":"Clopidogrel 0.2 mg/kg/Day","deltaMin":2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":null},"locations":{"siteCount":15,"countries":["United States","Brazil","France","Germany","Hungary","India","Italy","Malaysia","Mexico","Poland","Portugal","Russia","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["22269735"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":23},"commonTop":["Any infections and infestations","Any gastrointestinal disorders","Any general disorders and administration site conditions","Upper respiratory tract infection","Any respiratory, thoracic and mediastinal disorders"]}}